Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors

Summary

To determine whether special tumor fighting cells that is taken from participants' tumors and grown in the laboratory and then given back to the participant will fight the participant's cancer when their immune system is suppressed from attacking these special tumor fighting cells.

Timeline

Start

2020-10-07

Primary completion

2023-01-26

Completion

2023-01-26

Outcome

Outcome not reported

Stopped: “Closed because of feasibility and safety issues, didn't reach our end point”

Drugs

Indications